CircMIB1 inhibits glioma development and progression through a competing endogenous RNA interaction network
2024

CircMIB1 and Its Role in Glioma

Sample size: 76 publication 10 minutes Evidence: moderate

Author Information

Author(s): Chen Simin, Li Longping, Xu Wei, Xie Nanjiao, Xu Huiting, Zhou Yongjun, Zou Ying, Yi Kai, Liu Yi

Primary Institution: Yiyang Central Hospital, Yiyang, Hunan, China

Hypothesis

This study aimed to explore the role and potential molecular mechanisms of circRNA-mind bomb homolog 1 (circMIB1) in gliomas.

Conclusion

CircMIB1 is significantly downregulated in glioma tissues and cells, correlating with tumor grade and patient survival, suggesting its potential as a biomarker for glioma.

Supporting Evidence

  • The expression of circMIB1 was significantly downregulated in glioma cells and tissues.
  • CircMIB1 expression was closely associated with tumor grade and survival prognosis of glioma patients.
  • Patients with high circMIB1 expression had a significantly longer survival rate compared to those with low expression.

Takeaway

CircMIB1 is a molecule that is found less in brain tumors called gliomas, and it might help doctors understand how serious the tumor is and how to treat it better.

Methodology

RNA sequencing and quantitative real-time polymerase chain reaction were used to analyze circMIB1 expression in glioma and normal brain tissues.

Limitations

The sample size was relatively small and not comprehensive, and functional tests of circMIB1 have not yet been performed.

Participant Demographics

76 glioma patients and 17 non-tumor brain tissue samples were included.

Statistical Information

P-Value

p<0.0001

Confidence Interval

95% CI: 0.6326–0.9543

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.3389/fmolb.2024.1513919

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication